Impact of adoption of a decision algorithm including PCA3 for repeat biopsy on the costs for prostate cancer diagnosis in France
Bernard Malavaud(Université Toulouse III - Paul Sabatier), Herman Stoevelaar(Barnes-Jewish Hospital), Olivier Cussenot(Sorbonne Université), Louis Smets, François Rozet(Institute Mutualiste Montsouris), Nicolas Mottet(Centre Hospitalier Universitaire de Saint-Étienne), A. Ruffion(Université de Lyon)
Cited by 15
Related Papers
Genome-wide association study of prostate cancer identifies a second risk locus at 8q24
|Nature Genetics|2007|1.1k
Multiple loci identified in a genome-wide association study of prostate cancer
|Nature Genetics|2008|907
Management of Patients with Advanced Prostate Cancer: The Report of the Advanced Prostate Cancer Consensus Conference APCCC 2017
|European Urology|2017|644